Serveur d'exploration sur les dispositifs haptiques

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Comparison of AcrySof MA30BA and Sensar AR40 acrylic intraocular lenses

Identifieur interne : 001253 ( PascalFrancis/Corpus ); précédent : 001252; suivant : 001254

Comparison of AcrySof MA30BA and Sensar AR40 acrylic intraocular lenses

Auteurs : Fabrizio Casprini ; Gian Marco Tosi ; Pier Paolo Quercioli ; Aldo Caporossi

Source :

RBID : Pascal:02-0421659

Descripteurs français

English descriptors

Abstract

Purpose: To compare differences in anterior (ACO) and posterior (PCO) capsule opacification and subjective glare between 2 acrylic intraocular lenses (lOLs): AcrySof® MA30BA (Alcon) and Sensar® AR40 (Allergan). Setting: Department of Ophthalmology and Neurosurgery, University of Siena, Siena, Italy. Methods: This retrospective study comprised 100 cataract patients who had phacoemulsification and IOL implantation. Fifty eyes of 50 patients received an MA30BA and 50 eyes of 50 patients, an AR40. The mean postoperative follow-up was 25 months (range 20 to 31 months) and 22 months (range 19 to 29 months), respectively. Examiners subjectively evaluated ACO, and a photographic image-analysis system was used to assess PCO. All patients received a questionnaire to evaluate the incidence of subjective photic phenomena. Results: In the MA30BA group, 60% had no ACO, 19% had mild ACO, and 21% had anterior capsule fibrosis. In the AR40 group, 55% had no ACO, 27% had mild ACO, and 18% had anterior capsule fibrosis. In the MA30BA group, the mean PCO score measured by image-analysis was 0.043 (range 0.000 to 0.084) at 1 year and 0.125 (range 0.000 to 0.197) at 2 years and in the AR40 group, 0.071 (range 0.000 to 0.157) and 0.230 (range 0.091 to 0.628), respectively. Although the ACO percentages and the PCO scores at 1 year were not statistically different between the 2 groups (P >.05), the MA30BA group had statistically less PCO at 2 years (P <.05). In the MA30BA group, 36 patients had trouble reading in a dim environment, 25 had difficulty driving at night, 25 were mildly bothered by the lights of other vehicles, and 17 saw halos when looking at the lights of other vehicles and 17, when looking at lights at night. In the AR40 group, 7 patients had trouble reading in a dim environment and 11 had difficulty driving at night. At 6 months, the AR40 group had a statistically significantly lower incidence of photic phenomena than the MA30BA group (P <.05). In the MA30BA group 1 year after surgery, 13 patients had trouble reading in a dim environment and 12 had difficulty driving at night. In the AR40 group, 5 patients had trouble reading in a dim environment and 8 had difficulty driving at night. One year after surgery, the difference between the 2 groups in photic phenomena was not statistically significant (P >.05). Conclusions: The findings indicate that the AcrySof MA30BA has a lower incidence of PCO than the Sensar AR40. The AR40 IOL induced less glare; however, the glare phenomena did not disturb those with an MA30BA lens and the symptoms decreased by 1 year after surgery. These results suggest that both optic design and haptic material influence postoperative clinical results.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

pA  
A01 01  1    @0 0886-3350
A02 01      @0 JCSUEV
A03   1    @0 J. cataract refractive surg.
A05       @2 28
A06       @2 7
A08 01  1  ENG  @1 Comparison of AcrySof MA30BA and Sensar AR40 acrylic intraocular lenses
A11 01  1    @1 CASPRINI (Fabrizio)
A11 02  1    @1 TOSI (Gian Marco)
A11 03  1    @1 QUERCIOLI (Pier Paolo)
A11 04  1    @1 CAPOROSSI (Aldo)
A14 01      @1 Department of Ophthalmology and Neurosurgery, University of Siena @2 Siena @3 ITA @Z 1 aut. @Z 2 aut. @Z 3 aut. @Z 4 aut.
A20       @1 1130-1134
A21       @1 2002
A23 01      @0 ENG
A43 01      @1 INIST @2 20937 @5 354000108890470050
A44       @0 0000 @1 © 2002 INIST-CNRS. All rights reserved.
A45       @0 16 ref.
A47 01  1    @0 02-0421659
A60       @1 P
A61       @0 A
A64 01  1    @0 Journal of cataract and refractive surgery
A66 01      @0 USA
C01 01    ENG  @0 Purpose: To compare differences in anterior (ACO) and posterior (PCO) capsule opacification and subjective glare between 2 acrylic intraocular lenses (lOLs): AcrySof® MA30BA (Alcon) and Sensar® AR40 (Allergan). Setting: Department of Ophthalmology and Neurosurgery, University of Siena, Siena, Italy. Methods: This retrospective study comprised 100 cataract patients who had phacoemulsification and IOL implantation. Fifty eyes of 50 patients received an MA30BA and 50 eyes of 50 patients, an AR40. The mean postoperative follow-up was 25 months (range 20 to 31 months) and 22 months (range 19 to 29 months), respectively. Examiners subjectively evaluated ACO, and a photographic image-analysis system was used to assess PCO. All patients received a questionnaire to evaluate the incidence of subjective photic phenomena. Results: In the MA30BA group, 60% had no ACO, 19% had mild ACO, and 21% had anterior capsule fibrosis. In the AR40 group, 55% had no ACO, 27% had mild ACO, and 18% had anterior capsule fibrosis. In the MA30BA group, the mean PCO score measured by image-analysis was 0.043 (range 0.000 to 0.084) at 1 year and 0.125 (range 0.000 to 0.197) at 2 years and in the AR40 group, 0.071 (range 0.000 to 0.157) and 0.230 (range 0.091 to 0.628), respectively. Although the ACO percentages and the PCO scores at 1 year were not statistically different between the 2 groups (P >.05), the MA30BA group had statistically less PCO at 2 years (P <.05). In the MA30BA group, 36 patients had trouble reading in a dim environment, 25 had difficulty driving at night, 25 were mildly bothered by the lights of other vehicles, and 17 saw halos when looking at the lights of other vehicles and 17, when looking at lights at night. In the AR40 group, 7 patients had trouble reading in a dim environment and 11 had difficulty driving at night. At 6 months, the AR40 group had a statistically significantly lower incidence of photic phenomena than the MA30BA group (P <.05). In the MA30BA group 1 year after surgery, 13 patients had trouble reading in a dim environment and 12 had difficulty driving at night. In the AR40 group, 5 patients had trouble reading in a dim environment and 8 had difficulty driving at night. One year after surgery, the difference between the 2 groups in photic phenomena was not statistically significant (P >.05). Conclusions: The findings indicate that the AcrySof MA30BA has a lower incidence of PCO than the Sensar AR40. The AR40 IOL induced less glare; however, the glare phenomena did not disturb those with an MA30BA lens and the symptoms decreased by 1 year after surgery. These results suggest that both optic design and haptic material influence postoperative clinical results.
C02 01  X    @0 002B25B
C03 01  X  FRE  @0 Cataracte @5 01
C03 01  X  ENG  @0 Cataract @5 01
C03 01  X  SPA  @0 Catarata @5 01
C03 02  X  FRE  @0 Phacoémulsification @5 02
C03 02  X  ENG  @0 Phacoemulsification @5 02
C03 02  X  SPA  @0 Facoemulsificación @5 02
C03 03  X  FRE  @0 Traitement @5 03
C03 03  X  ENG  @0 Treatment @5 03
C03 03  X  SPA  @0 Tratamiento @5 03
C03 04  X  FRE  @0 Lentille intraoculaire @5 04
C03 04  X  ENG  @0 Intraocular lens @5 04
C03 04  X  SPA  @0 Lente intraocular @5 04
C03 05  X  FRE  @0 Implantation @5 05
C03 05  X  ENG  @0 Implantation @5 05
C03 05  X  SPA  @0 Implantación @5 05
C03 06  X  FRE  @0 Etude comparative @5 06
C03 06  X  ENG  @0 Comparative study @5 06
C03 06  X  SPA  @0 Estudio comparativo @5 06
C03 07  X  FRE  @0 Acrylique dérivé polymère @2 NK @5 07
C03 07  X  ENG  @0 Acrylic polymer @2 NK @5 07
C03 07  X  SPA  @0 Acrilico derivado polímero @2 NK @5 07
C03 08  X  FRE  @0 Siloxane polymère @2 NK @5 08
C03 08  X  ENG  @0 Siloxane polymer @2 NK @5 08
C03 08  X  SPA  @0 Siloxano polímero @2 NK @5 08
C03 09  X  FRE  @0 Complication @5 09
C03 09  X  ENG  @0 Complication @5 09
C03 09  X  SPA  @0 Complicación @5 09
C03 10  X  FRE  @0 Opacification @5 10
C03 10  X  ENG  @0 Opacification @5 10
C03 10  X  SPA  @0 Opacificación @5 10
C03 11  X  FRE  @0 Capsule @5 11
C03 11  X  ENG  @0 Capsule @5 11
C03 11  X  SPA  @0 Cápsula @5 11
C03 12  X  FRE  @0 Postérieur @5 12
C03 12  X  ENG  @0 Posterior @5 12
C03 12  X  SPA  @0 Posterior @5 12
C03 13  X  FRE  @0 Antérieur @5 13
C03 13  X  ENG  @0 Anterior @5 13
C03 13  X  SPA  @0 Anterior @5 13
C03 14  X  FRE  @0 Homme @5 17
C03 14  X  ENG  @0 Human @5 17
C03 14  X  SPA  @0 Hombre @5 17
C03 15  X  FRE  @0 Biomatériau @5 18
C03 15  X  ENG  @0 Biomaterial @5 18
C03 15  X  SPA  @0 Biomaterial @5 18
C03 16  X  FRE  @0 Postopératoire @5 20
C03 16  X  ENG  @0 Postoperative @5 20
C03 16  X  SPA  @0 Postoperatorio @5 20
C07 01  X  FRE  @0 Oeil pathologie @5 37
C07 01  X  ENG  @0 Eye disease @5 37
C07 01  X  SPA  @0 Ojo patología @5 37
C07 02  X  FRE  @0 Cristallin pathologie @5 38
C07 02  X  ENG  @0 Lens disease @5 38
C07 02  X  SPA  @0 Cristalino patología @5 38
C07 03  X  FRE  @0 Segment antérieur pathologie @2 NM @5 39
C07 03  X  ENG  @0 Anterior segment disease @2 NM @5 39
C07 03  X  SPA  @0 Segmento anterior patología @2 NM @5 39
C07 04  X  FRE  @0 Chirurgie @5 45
C07 04  X  ENG  @0 Surgery @5 45
C07 04  X  SPA  @0 Cirugía @5 45
N21       @1 245
N82       @1 PSI

Format Inist (serveur)

NO : PASCAL 02-0421659 INIST
ET : Comparison of AcrySof MA30BA and Sensar AR40 acrylic intraocular lenses
AU : CASPRINI (Fabrizio); TOSI (Gian Marco); QUERCIOLI (Pier Paolo); CAPOROSSI (Aldo)
AF : Department of Ophthalmology and Neurosurgery, University of Siena/Siena/Italie (1 aut., 2 aut., 3 aut., 4 aut.)
DT : Publication en série; Niveau analytique
SO : Journal of cataract and refractive surgery; ISSN 0886-3350; Coden JCSUEV; Etats-Unis; Da. 2002; Vol. 28; No. 7; Pp. 1130-1134; Bibl. 16 ref.
LA : Anglais
EA : Purpose: To compare differences in anterior (ACO) and posterior (PCO) capsule opacification and subjective glare between 2 acrylic intraocular lenses (lOLs): AcrySof® MA30BA (Alcon) and Sensar® AR40 (Allergan). Setting: Department of Ophthalmology and Neurosurgery, University of Siena, Siena, Italy. Methods: This retrospective study comprised 100 cataract patients who had phacoemulsification and IOL implantation. Fifty eyes of 50 patients received an MA30BA and 50 eyes of 50 patients, an AR40. The mean postoperative follow-up was 25 months (range 20 to 31 months) and 22 months (range 19 to 29 months), respectively. Examiners subjectively evaluated ACO, and a photographic image-analysis system was used to assess PCO. All patients received a questionnaire to evaluate the incidence of subjective photic phenomena. Results: In the MA30BA group, 60% had no ACO, 19% had mild ACO, and 21% had anterior capsule fibrosis. In the AR40 group, 55% had no ACO, 27% had mild ACO, and 18% had anterior capsule fibrosis. In the MA30BA group, the mean PCO score measured by image-analysis was 0.043 (range 0.000 to 0.084) at 1 year and 0.125 (range 0.000 to 0.197) at 2 years and in the AR40 group, 0.071 (range 0.000 to 0.157) and 0.230 (range 0.091 to 0.628), respectively. Although the ACO percentages and the PCO scores at 1 year were not statistically different between the 2 groups (P >.05), the MA30BA group had statistically less PCO at 2 years (P <.05). In the MA30BA group, 36 patients had trouble reading in a dim environment, 25 had difficulty driving at night, 25 were mildly bothered by the lights of other vehicles, and 17 saw halos when looking at the lights of other vehicles and 17, when looking at lights at night. In the AR40 group, 7 patients had trouble reading in a dim environment and 11 had difficulty driving at night. At 6 months, the AR40 group had a statistically significantly lower incidence of photic phenomena than the MA30BA group (P <.05). In the MA30BA group 1 year after surgery, 13 patients had trouble reading in a dim environment and 12 had difficulty driving at night. In the AR40 group, 5 patients had trouble reading in a dim environment and 8 had difficulty driving at night. One year after surgery, the difference between the 2 groups in photic phenomena was not statistically significant (P >.05). Conclusions: The findings indicate that the AcrySof MA30BA has a lower incidence of PCO than the Sensar AR40. The AR40 IOL induced less glare; however, the glare phenomena did not disturb those with an MA30BA lens and the symptoms decreased by 1 year after surgery. These results suggest that both optic design and haptic material influence postoperative clinical results.
CC : 002B25B
FD : Cataracte; Phacoémulsification; Traitement; Lentille intraoculaire; Implantation; Etude comparative; Acrylique dérivé polymère; Siloxane polymère; Complication; Opacification; Capsule; Postérieur; Antérieur; Homme; Biomatériau; Postopératoire
FG : Oeil pathologie; Cristallin pathologie; Segment antérieur pathologie; Chirurgie
ED : Cataract; Phacoemulsification; Treatment; Intraocular lens; Implantation; Comparative study; Acrylic polymer; Siloxane polymer; Complication; Opacification; Capsule; Posterior; Anterior; Human; Biomaterial; Postoperative
EG : Eye disease; Lens disease; Anterior segment disease; Surgery
SD : Catarata; Facoemulsificación; Tratamiento; Lente intraocular; Implantación; Estudio comparativo; Acrilico derivado polímero; Siloxano polímero; Complicación; Opacificación; Cápsula; Posterior; Anterior; Hombre; Biomaterial; Postoperatorio
LO : INIST-20937.354000108890470050
ID : 02-0421659

Links to Exploration step

Pascal:02-0421659

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Comparison of AcrySof MA30BA and Sensar AR40 acrylic intraocular lenses</title>
<author>
<name sortKey="Casprini, Fabrizio" sort="Casprini, Fabrizio" uniqKey="Casprini F" first="Fabrizio" last="Casprini">Fabrizio Casprini</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Ophthalmology and Neurosurgery, University of Siena</s1>
<s2>Siena</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Tosi, Gian Marco" sort="Tosi, Gian Marco" uniqKey="Tosi G" first="Gian Marco" last="Tosi">Gian Marco Tosi</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Ophthalmology and Neurosurgery, University of Siena</s1>
<s2>Siena</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Quercioli, Pier Paolo" sort="Quercioli, Pier Paolo" uniqKey="Quercioli P" first="Pier Paolo" last="Quercioli">Pier Paolo Quercioli</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Ophthalmology and Neurosurgery, University of Siena</s1>
<s2>Siena</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Caporossi, Aldo" sort="Caporossi, Aldo" uniqKey="Caporossi A" first="Aldo" last="Caporossi">Aldo Caporossi</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Ophthalmology and Neurosurgery, University of Siena</s1>
<s2>Siena</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">02-0421659</idno>
<date when="2002">2002</date>
<idno type="stanalyst">PASCAL 02-0421659 INIST</idno>
<idno type="RBID">Pascal:02-0421659</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001253</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Comparison of AcrySof MA30BA and Sensar AR40 acrylic intraocular lenses</title>
<author>
<name sortKey="Casprini, Fabrizio" sort="Casprini, Fabrizio" uniqKey="Casprini F" first="Fabrizio" last="Casprini">Fabrizio Casprini</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Ophthalmology and Neurosurgery, University of Siena</s1>
<s2>Siena</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Tosi, Gian Marco" sort="Tosi, Gian Marco" uniqKey="Tosi G" first="Gian Marco" last="Tosi">Gian Marco Tosi</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Ophthalmology and Neurosurgery, University of Siena</s1>
<s2>Siena</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Quercioli, Pier Paolo" sort="Quercioli, Pier Paolo" uniqKey="Quercioli P" first="Pier Paolo" last="Quercioli">Pier Paolo Quercioli</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Ophthalmology and Neurosurgery, University of Siena</s1>
<s2>Siena</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Caporossi, Aldo" sort="Caporossi, Aldo" uniqKey="Caporossi A" first="Aldo" last="Caporossi">Aldo Caporossi</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Ophthalmology and Neurosurgery, University of Siena</s1>
<s2>Siena</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Journal of cataract and refractive surgery</title>
<title level="j" type="abbreviated">J. cataract refractive surg.</title>
<idno type="ISSN">0886-3350</idno>
<imprint>
<date when="2002">2002</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Journal of cataract and refractive surgery</title>
<title level="j" type="abbreviated">J. cataract refractive surg.</title>
<idno type="ISSN">0886-3350</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Acrylic polymer</term>
<term>Anterior</term>
<term>Biomaterial</term>
<term>Capsule</term>
<term>Cataract</term>
<term>Comparative study</term>
<term>Complication</term>
<term>Human</term>
<term>Implantation</term>
<term>Intraocular lens</term>
<term>Opacification</term>
<term>Phacoemulsification</term>
<term>Posterior</term>
<term>Postoperative</term>
<term>Siloxane polymer</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Cataracte</term>
<term>Phacoémulsification</term>
<term>Traitement</term>
<term>Lentille intraoculaire</term>
<term>Implantation</term>
<term>Etude comparative</term>
<term>Acrylique dérivé polymère</term>
<term>Siloxane polymère</term>
<term>Complication</term>
<term>Opacification</term>
<term>Capsule</term>
<term>Postérieur</term>
<term>Antérieur</term>
<term>Homme</term>
<term>Biomatériau</term>
<term>Postopératoire</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Purpose: To compare differences in anterior (ACO) and posterior (PCO) capsule opacification and subjective glare between 2 acrylic intraocular lenses (lOLs): AcrySof® MA30BA (Alcon) and Sensar® AR40 (Allergan). Setting: Department of Ophthalmology and Neurosurgery, University of Siena, Siena, Italy. Methods: This retrospective study comprised 100 cataract patients who had phacoemulsification and IOL implantation. Fifty eyes of 50 patients received an MA30BA and 50 eyes of 50 patients, an AR40. The mean postoperative follow-up was 25 months (range 20 to 31 months) and 22 months (range 19 to 29 months), respectively. Examiners subjectively evaluated ACO, and a photographic image-analysis system was used to assess PCO. All patients received a questionnaire to evaluate the incidence of subjective photic phenomena. Results: In the MA30BA group, 60% had no ACO, 19% had mild ACO, and 21% had anterior capsule fibrosis. In the AR40 group, 55% had no ACO, 27% had mild ACO, and 18% had anterior capsule fibrosis. In the MA30BA group, the mean PCO score measured by image-analysis was 0.043 (range 0.000 to 0.084) at 1 year and 0.125 (range 0.000 to 0.197) at 2 years and in the AR40 group, 0.071 (range 0.000 to 0.157) and 0.230 (range 0.091 to 0.628), respectively. Although the ACO percentages and the PCO scores at 1 year were not statistically different between the 2 groups (P >.05), the MA30BA group had statistically less PCO at 2 years (P <.05). In the MA30BA group, 36 patients had trouble reading in a dim environment, 25 had difficulty driving at night, 25 were mildly bothered by the lights of other vehicles, and 17 saw halos when looking at the lights of other vehicles and 17, when looking at lights at night. In the AR40 group, 7 patients had trouble reading in a dim environment and 11 had difficulty driving at night. At 6 months, the AR40 group had a statistically significantly lower incidence of photic phenomena than the MA30BA group (P <.05). In the MA30BA group 1 year after surgery, 13 patients had trouble reading in a dim environment and 12 had difficulty driving at night. In the AR40 group, 5 patients had trouble reading in a dim environment and 8 had difficulty driving at night. One year after surgery, the difference between the 2 groups in photic phenomena was not statistically significant (P >.05). Conclusions: The findings indicate that the AcrySof MA30BA has a lower incidence of PCO than the Sensar AR40. The AR40 IOL induced less glare; however, the glare phenomena did not disturb those with an MA30BA lens and the symptoms decreased by 1 year after surgery. These results suggest that both optic design and haptic material influence postoperative clinical results.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0886-3350</s0>
</fA01>
<fA02 i1="01">
<s0>JCSUEV</s0>
</fA02>
<fA03 i2="1">
<s0>J. cataract refractive surg.</s0>
</fA03>
<fA05>
<s2>28</s2>
</fA05>
<fA06>
<s2>7</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Comparison of AcrySof MA30BA and Sensar AR40 acrylic intraocular lenses</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>CASPRINI (Fabrizio)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>TOSI (Gian Marco)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>QUERCIOLI (Pier Paolo)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>CAPOROSSI (Aldo)</s1>
</fA11>
<fA14 i1="01">
<s1>Department of Ophthalmology and Neurosurgery, University of Siena</s1>
<s2>Siena</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</fA14>
<fA20>
<s1>1130-1134</s1>
</fA20>
<fA21>
<s1>2002</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>20937</s2>
<s5>354000108890470050</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2002 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>16 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>02-0421659</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Journal of cataract and refractive surgery</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>Purpose: To compare differences in anterior (ACO) and posterior (PCO) capsule opacification and subjective glare between 2 acrylic intraocular lenses (lOLs): AcrySof® MA30BA (Alcon) and Sensar® AR40 (Allergan). Setting: Department of Ophthalmology and Neurosurgery, University of Siena, Siena, Italy. Methods: This retrospective study comprised 100 cataract patients who had phacoemulsification and IOL implantation. Fifty eyes of 50 patients received an MA30BA and 50 eyes of 50 patients, an AR40. The mean postoperative follow-up was 25 months (range 20 to 31 months) and 22 months (range 19 to 29 months), respectively. Examiners subjectively evaluated ACO, and a photographic image-analysis system was used to assess PCO. All patients received a questionnaire to evaluate the incidence of subjective photic phenomena. Results: In the MA30BA group, 60% had no ACO, 19% had mild ACO, and 21% had anterior capsule fibrosis. In the AR40 group, 55% had no ACO, 27% had mild ACO, and 18% had anterior capsule fibrosis. In the MA30BA group, the mean PCO score measured by image-analysis was 0.043 (range 0.000 to 0.084) at 1 year and 0.125 (range 0.000 to 0.197) at 2 years and in the AR40 group, 0.071 (range 0.000 to 0.157) and 0.230 (range 0.091 to 0.628), respectively. Although the ACO percentages and the PCO scores at 1 year were not statistically different between the 2 groups (P >.05), the MA30BA group had statistically less PCO at 2 years (P <.05). In the MA30BA group, 36 patients had trouble reading in a dim environment, 25 had difficulty driving at night, 25 were mildly bothered by the lights of other vehicles, and 17 saw halos when looking at the lights of other vehicles and 17, when looking at lights at night. In the AR40 group, 7 patients had trouble reading in a dim environment and 11 had difficulty driving at night. At 6 months, the AR40 group had a statistically significantly lower incidence of photic phenomena than the MA30BA group (P <.05). In the MA30BA group 1 year after surgery, 13 patients had trouble reading in a dim environment and 12 had difficulty driving at night. In the AR40 group, 5 patients had trouble reading in a dim environment and 8 had difficulty driving at night. One year after surgery, the difference between the 2 groups in photic phenomena was not statistically significant (P >.05). Conclusions: The findings indicate that the AcrySof MA30BA has a lower incidence of PCO than the Sensar AR40. The AR40 IOL induced less glare; however, the glare phenomena did not disturb those with an MA30BA lens and the symptoms decreased by 1 year after surgery. These results suggest that both optic design and haptic material influence postoperative clinical results.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B25B</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Cataracte</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Cataract</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Catarata</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Phacoémulsification</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Phacoemulsification</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Facoemulsificación</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Traitement</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Treatment</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Tratamiento</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Lentille intraoculaire</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Intraocular lens</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Lente intraocular</s0>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Implantation</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Implantation</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Implantación</s0>
<s5>05</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Etude comparative</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Comparative study</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Estudio comparativo</s0>
<s5>06</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Acrylique dérivé polymère</s0>
<s2>NK</s2>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Acrylic polymer</s0>
<s2>NK</s2>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Acrilico derivado polímero</s0>
<s2>NK</s2>
<s5>07</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE">
<s0>Siloxane polymère</s0>
<s2>NK</s2>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG">
<s0>Siloxane polymer</s0>
<s2>NK</s2>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA">
<s0>Siloxano polímero</s0>
<s2>NK</s2>
<s5>08</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE">
<s0>Complication</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG">
<s0>Complication</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA">
<s0>Complicación</s0>
<s5>09</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE">
<s0>Opacification</s0>
<s5>10</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG">
<s0>Opacification</s0>
<s5>10</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA">
<s0>Opacificación</s0>
<s5>10</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE">
<s0>Capsule</s0>
<s5>11</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG">
<s0>Capsule</s0>
<s5>11</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA">
<s0>Cápsula</s0>
<s5>11</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE">
<s0>Postérieur</s0>
<s5>12</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG">
<s0>Posterior</s0>
<s5>12</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA">
<s0>Posterior</s0>
<s5>12</s5>
</fC03>
<fC03 i1="13" i2="X" l="FRE">
<s0>Antérieur</s0>
<s5>13</s5>
</fC03>
<fC03 i1="13" i2="X" l="ENG">
<s0>Anterior</s0>
<s5>13</s5>
</fC03>
<fC03 i1="13" i2="X" l="SPA">
<s0>Anterior</s0>
<s5>13</s5>
</fC03>
<fC03 i1="14" i2="X" l="FRE">
<s0>Homme</s0>
<s5>17</s5>
</fC03>
<fC03 i1="14" i2="X" l="ENG">
<s0>Human</s0>
<s5>17</s5>
</fC03>
<fC03 i1="14" i2="X" l="SPA">
<s0>Hombre</s0>
<s5>17</s5>
</fC03>
<fC03 i1="15" i2="X" l="FRE">
<s0>Biomatériau</s0>
<s5>18</s5>
</fC03>
<fC03 i1="15" i2="X" l="ENG">
<s0>Biomaterial</s0>
<s5>18</s5>
</fC03>
<fC03 i1="15" i2="X" l="SPA">
<s0>Biomaterial</s0>
<s5>18</s5>
</fC03>
<fC03 i1="16" i2="X" l="FRE">
<s0>Postopératoire</s0>
<s5>20</s5>
</fC03>
<fC03 i1="16" i2="X" l="ENG">
<s0>Postoperative</s0>
<s5>20</s5>
</fC03>
<fC03 i1="16" i2="X" l="SPA">
<s0>Postoperatorio</s0>
<s5>20</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Oeil pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Eye disease</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Ojo patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Cristallin pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Lens disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Cristalino patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Segment antérieur pathologie</s0>
<s2>NM</s2>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Anterior segment disease</s0>
<s2>NM</s2>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Segmento anterior patología</s0>
<s2>NM</s2>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Chirurgie</s0>
<s5>45</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Surgery</s0>
<s5>45</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Cirugía</s0>
<s5>45</s5>
</fC07>
<fN21>
<s1>245</s1>
</fN21>
<fN82>
<s1>PSI</s1>
</fN82>
</pA>
</standard>
<server>
<NO>PASCAL 02-0421659 INIST</NO>
<ET>Comparison of AcrySof MA30BA and Sensar AR40 acrylic intraocular lenses</ET>
<AU>CASPRINI (Fabrizio); TOSI (Gian Marco); QUERCIOLI (Pier Paolo); CAPOROSSI (Aldo)</AU>
<AF>Department of Ophthalmology and Neurosurgery, University of Siena/Siena/Italie (1 aut., 2 aut., 3 aut., 4 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Journal of cataract and refractive surgery; ISSN 0886-3350; Coden JCSUEV; Etats-Unis; Da. 2002; Vol. 28; No. 7; Pp. 1130-1134; Bibl. 16 ref.</SO>
<LA>Anglais</LA>
<EA>Purpose: To compare differences in anterior (ACO) and posterior (PCO) capsule opacification and subjective glare between 2 acrylic intraocular lenses (lOLs): AcrySof® MA30BA (Alcon) and Sensar® AR40 (Allergan). Setting: Department of Ophthalmology and Neurosurgery, University of Siena, Siena, Italy. Methods: This retrospective study comprised 100 cataract patients who had phacoemulsification and IOL implantation. Fifty eyes of 50 patients received an MA30BA and 50 eyes of 50 patients, an AR40. The mean postoperative follow-up was 25 months (range 20 to 31 months) and 22 months (range 19 to 29 months), respectively. Examiners subjectively evaluated ACO, and a photographic image-analysis system was used to assess PCO. All patients received a questionnaire to evaluate the incidence of subjective photic phenomena. Results: In the MA30BA group, 60% had no ACO, 19% had mild ACO, and 21% had anterior capsule fibrosis. In the AR40 group, 55% had no ACO, 27% had mild ACO, and 18% had anterior capsule fibrosis. In the MA30BA group, the mean PCO score measured by image-analysis was 0.043 (range 0.000 to 0.084) at 1 year and 0.125 (range 0.000 to 0.197) at 2 years and in the AR40 group, 0.071 (range 0.000 to 0.157) and 0.230 (range 0.091 to 0.628), respectively. Although the ACO percentages and the PCO scores at 1 year were not statistically different between the 2 groups (P >.05), the MA30BA group had statistically less PCO at 2 years (P <.05). In the MA30BA group, 36 patients had trouble reading in a dim environment, 25 had difficulty driving at night, 25 were mildly bothered by the lights of other vehicles, and 17 saw halos when looking at the lights of other vehicles and 17, when looking at lights at night. In the AR40 group, 7 patients had trouble reading in a dim environment and 11 had difficulty driving at night. At 6 months, the AR40 group had a statistically significantly lower incidence of photic phenomena than the MA30BA group (P <.05). In the MA30BA group 1 year after surgery, 13 patients had trouble reading in a dim environment and 12 had difficulty driving at night. In the AR40 group, 5 patients had trouble reading in a dim environment and 8 had difficulty driving at night. One year after surgery, the difference between the 2 groups in photic phenomena was not statistically significant (P >.05). Conclusions: The findings indicate that the AcrySof MA30BA has a lower incidence of PCO than the Sensar AR40. The AR40 IOL induced less glare; however, the glare phenomena did not disturb those with an MA30BA lens and the symptoms decreased by 1 year after surgery. These results suggest that both optic design and haptic material influence postoperative clinical results.</EA>
<CC>002B25B</CC>
<FD>Cataracte; Phacoémulsification; Traitement; Lentille intraoculaire; Implantation; Etude comparative; Acrylique dérivé polymère; Siloxane polymère; Complication; Opacification; Capsule; Postérieur; Antérieur; Homme; Biomatériau; Postopératoire</FD>
<FG>Oeil pathologie; Cristallin pathologie; Segment antérieur pathologie; Chirurgie</FG>
<ED>Cataract; Phacoemulsification; Treatment; Intraocular lens; Implantation; Comparative study; Acrylic polymer; Siloxane polymer; Complication; Opacification; Capsule; Posterior; Anterior; Human; Biomaterial; Postoperative</ED>
<EG>Eye disease; Lens disease; Anterior segment disease; Surgery</EG>
<SD>Catarata; Facoemulsificación; Tratamiento; Lente intraocular; Implantación; Estudio comparativo; Acrilico derivado polímero; Siloxano polímero; Complicación; Opacificación; Cápsula; Posterior; Anterior; Hombre; Biomaterial; Postoperatorio</SD>
<LO>INIST-20937.354000108890470050</LO>
<ID>02-0421659</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Ticri/CIDE/explor/HapticV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001253 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 001253 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Ticri/CIDE
   |area=    HapticV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:02-0421659
   |texte=   Comparison of AcrySof MA30BA and Sensar AR40 acrylic intraocular lenses
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Mon Jun 13 01:09:46 2016. Site generation: Wed Mar 6 09:54:07 2024